Pi Health, a startup that deploys artificial intelligence in the field of cancer treatment trials, raised more than $30 million in funding to further develop its technology and tie new partnerships.
Pi Health’s platform helps clinical trial researchers recruit cancer patients across the U.S., Brazil, Australia and India, allowing drug makers to draw from a diverse genetic pool. The disease is widespread across all strata of populations around the globe, but less than 5% of adults with cancer enroll in clinical studies — a group Pi Health wants to broaden.
